Home | Business News | CBJ Newsmakers | Tetra Bio-Pharma’s Subsidiary, Panag Pharma, Obtains Health Canada Authorization to Commence Its First Veterinary Clinical Study Tetra Bio-Pharma’s Subsidiary, Panag Pharma, Obtains Health Canada Authorization to Commence Its First Veterinary Clinical Study CBJ Newsmakers RecommendedRetail Sales Down in MayCanadian Life Companies Split Corp. Financial Results to May 31, 2021Financial 15 Split Corp. Financial Results to May 31, 2021
